Literature DB >> 20013699

[Leptin serum levels in cachectic and non-cachectic lung cancer patients].

Bozena Weryńska, Monika Kosacka, Marcin Gołecki, Renata Jankowska.   

Abstract

INTRODUCTION: Leptin, protein taking part in body mass regulation, might play a role in cancer cachexia development. The aim of the study was to measure leptin serum levels in cachectic, non-cachectic lung cancer patients, healthy controls and to correlate leptin concentration with nutritional status markers.
MATERIAL AND METHODS: 40 lung cancer patients were enrolled into the study: 20 with cachexia, 20 without cachexia, and 10 healthy controls. Leptin serum concentration, body mass, BMI, arm circumference and skin triceps fold thickness were measured in each subject.
RESULTS: Serum leptin level in cachectic cancer patients was significantly lower than in non-cachectic and healthy controls. Leptin concentration correlated with body mass, arm circumference and skin triceps fold thickness.
CONCLUSIONS: Cachectic lung cancer patients have significantly lower serum leptin concentrations than non-cachectic patients and healthy controls which may suggest, that leptin does not play an important role in cancer cachexia development. Leptin levels positively correlate with good nutritional status markers. Non-cachectic lung cancer patients have similar leptin serum levels as healthy controls.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20013699

Source DB:  PubMed          Journal:  Pneumonol Alergol Pol        ISSN: 0867-7077


  8 in total

1.  Adipokines and systemic inflammation in weight-losing lung cancer patients.

Authors:  Sule T Gulen; Fisun Karadag; Aslihan B Karul; Naciye Kilicarslan; Emel Ceylan; Nilgun K Kuman; Orhan Cildag
Journal:  Lung       Date:  2012-01-14       Impact factor: 2.584

Review 2.  Metabolic Reprogramming in Adipose Tissue During Cancer Cachexia.

Authors:  Bahar Zehra Camurdanoglu Weber; Dilsad H Arabaci; Serkan Kir
Journal:  Front Oncol       Date:  2022-05-12       Impact factor: 5.738

3.  Leptin in anorexia and cachexia syndrome.

Authors:  Diana R Engineer; Jose M Garcia
Journal:  Int J Pept       Date:  2012-02-08

4.  Emerging markers of cachexia predict survival in cancer patients.

Authors:  Patrizia Mondello; Antonio Lacquaniti; Stefania Mondello; Davide Bolignano; Vincenzo Pitini; Carmela Aloisi; Michele Buemi
Journal:  BMC Cancer       Date:  2014-11-16       Impact factor: 4.430

5.  Serum and tissue leptin in lung cancer: A meta-analysis.

Authors:  Xiang Tong; Yao Ma; Qilong Zhou; Jie He; Bo Peng; Sitong Liu; Zhipeng Yan; Xin Yang; Hong Fan
Journal:  Oncotarget       Date:  2017-03-21

6.  A systematic review of the overlap of fluid biomarkers in delirium and advanced cancer-related syndromes.

Authors:  Ingrid Amgarth-Duff; Annmarie Hosie; Gideon Caplan; Meera Agar
Journal:  BMC Psychiatry       Date:  2020-04-22       Impact factor: 3.630

Review 7.  [Advances of the relationship between leptin system and non-small cell lung cancer].

Authors:  Tengfei Wei; Longkun Lu; Qian Shen; Chaoping Fang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2014-04

Review 8.  Potential Biomarkers of Fat Loss as a Feature of Cancer Cachexia.

Authors:  Maryam Ebadi; Vera C Mazurak
Journal:  Mediators Inflamm       Date:  2015-10-05       Impact factor: 4.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.